-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Spruce Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q2 2024.
- Spruce Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$10M, a 28.2% increase year-over-year.
- Spruce Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$47.5M, a 6.59% increase year-over-year.
- Spruce Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$52M, a 9.96% decline from 2022.
- Spruce Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$47.3M, a 12.4% decline from 2021.
- Spruce Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$42.1M, a 43% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)